MOBIX LABS INC (MOBX)

US60743G1004 - Common Stock

0.7213  -0.01 (-1.6%)

After market: 0.7001 -0.02 (-2.94%)

Fundamental Rating

0

Overall MOBX gets a fundamental rating of 0 out of 10. We evaluated MOBX against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. MOBX has a bad profitability rating. Also its financial health evaluation is rather negative. MOBX has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

MOBX had negative earnings in the past year.
In the past year MOBX has reported a negative cash flow from operations.

1.2 Ratios

MOBX has a worse Return On Assets (-62.95%) than 89.81% of its industry peers.
MOBX has a worse Return On Equity (-447.10%) than 91.67% of its industry peers.
Industry RankSector Rank
ROA -62.95%
ROE -447.1%
ROIC N/A
ROA(3y)-5.03%
ROA(5y)N/A
ROE(3y)-6.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MOBX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

The number of shares outstanding for MOBX remains at a similar level compared to 1 year ago.
MOBX has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -8.51, we must say that MOBX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.51, MOBX is doing worse than 83.33% of the companies in the same industry.
A Debt/Equity ratio of 0.76 indicates that MOBX is somewhat dependend on debt financing.
MOBX's Debt to Equity ratio of 0.76 is on the low side compared to the rest of the industry. MOBX is outperformed by 82.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z -8.51
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

MOBX has a Current Ratio of 0.25. This is a bad value and indicates that MOBX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MOBX (0.25) is worse than 97.22% of its industry peers.
A Quick Ratio of 0.23 indicates that MOBX may have some problems paying its short term obligations.
MOBX's Quick ratio of 0.23 is on the low side compared to the rest of the industry. MOBX is outperformed by 97.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.23

0

3. Growth

3.1 Past

The earnings per share for MOBX have decreased by -6.30% in the last year.
EPS 1Y (TTM)-6.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

MOBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MOBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MOBIX LABS INC

NASDAQ:MOBX (11/25/2024, 7:33:06 PM)

After market: 0.7001 -0.02 (-2.94%)

0.7213

-0.01 (-1.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap22.06M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.95%
ROE -447.1%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.25
Quick Ratio 0.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-6.3%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y